The role of peroxiredoxin II in chemoresistance of breast cancer cells

Tieli Wang, Anthony Joseph Gomez Diaz, Yun Yen

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Peroxiredoxin (Prx)II belongs to a family of redox-active proteins that use redox-sensitive cysteine in the active site to reduce peroxides. PrxII is induced by various oxidative stimuli and plays an important protective role against oxidative radical damage by reactive oxygen species. PrxII expression levels are correlated with resistance to radiation therapy or certain anti-cancer drugs in radioresistant breast cancer cells, glioblastomas, and head and neck cancer cells as well as in tissue isolated from head and neck patients who do not respond to radiation therapy. Small interfering RNA (siRNA) that inhibits the PrxII gene expression has been shown to partially reverse the radioresistant phenotype in radiation resistant breast cancer cells and sensitizes glioma cells to oxidative stress, highlighting the potential clinical importance of PrxII in radiation resistance in cancer. This article focuses on the role that PrxII may play in chemoresistant breast cancer cells.

Original languageEnglish
Pages (from-to)73-80
Number of pages8
JournalBreast Cancer: Targets and Therapy
Volume6
DOIs
Publication statusPublished - 2014
Externally publishedYes

Fingerprint

Peroxiredoxins
Breast Neoplasms
Oxidation-Reduction
Radiotherapy
Radiation
Peroxides
Glioblastoma
Head and Neck Neoplasms
Glioma
Small Interfering RNA
Cysteine
Reactive Oxygen Species
Catalytic Domain
Neoplasms
Oxidative Stress
Neck
Head
Phenotype
Gene Expression
Pharmaceutical Preparations

Keywords

  • Cysteine disulfide bridges
  • Reactive oxygen species
  • Redox
  • siRNA
  • Targeted therapy

ASJC Scopus subject areas

  • Oncology

Cite this

The role of peroxiredoxin II in chemoresistance of breast cancer cells. / Wang, Tieli; Diaz, Anthony Joseph Gomez; Yen, Yun.

In: Breast Cancer: Targets and Therapy, Vol. 6, 2014, p. 73-80.

Research output: Contribution to journalArticle

Wang, Tieli ; Diaz, Anthony Joseph Gomez ; Yen, Yun. / The role of peroxiredoxin II in chemoresistance of breast cancer cells. In: Breast Cancer: Targets and Therapy. 2014 ; Vol. 6. pp. 73-80.
@article{55a65844c9e44459bdb95e613c48ec65,
title = "The role of peroxiredoxin II in chemoresistance of breast cancer cells",
abstract = "Peroxiredoxin (Prx)II belongs to a family of redox-active proteins that use redox-sensitive cysteine in the active site to reduce peroxides. PrxII is induced by various oxidative stimuli and plays an important protective role against oxidative radical damage by reactive oxygen species. PrxII expression levels are correlated with resistance to radiation therapy or certain anti-cancer drugs in radioresistant breast cancer cells, glioblastomas, and head and neck cancer cells as well as in tissue isolated from head and neck patients who do not respond to radiation therapy. Small interfering RNA (siRNA) that inhibits the PrxII gene expression has been shown to partially reverse the radioresistant phenotype in radiation resistant breast cancer cells and sensitizes glioma cells to oxidative stress, highlighting the potential clinical importance of PrxII in radiation resistance in cancer. This article focuses on the role that PrxII may play in chemoresistant breast cancer cells.",
keywords = "Cysteine disulfide bridges, Reactive oxygen species, Redox, siRNA, Targeted therapy",
author = "Tieli Wang and Diaz, {Anthony Joseph Gomez} and Yun Yen",
year = "2014",
doi = "10.2147/BCTT.S61281",
language = "English",
volume = "6",
pages = "73--80",
journal = "Breast Cancer: Targets and Therapy",
issn = "1179-1314",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - The role of peroxiredoxin II in chemoresistance of breast cancer cells

AU - Wang, Tieli

AU - Diaz, Anthony Joseph Gomez

AU - Yen, Yun

PY - 2014

Y1 - 2014

N2 - Peroxiredoxin (Prx)II belongs to a family of redox-active proteins that use redox-sensitive cysteine in the active site to reduce peroxides. PrxII is induced by various oxidative stimuli and plays an important protective role against oxidative radical damage by reactive oxygen species. PrxII expression levels are correlated with resistance to radiation therapy or certain anti-cancer drugs in radioresistant breast cancer cells, glioblastomas, and head and neck cancer cells as well as in tissue isolated from head and neck patients who do not respond to radiation therapy. Small interfering RNA (siRNA) that inhibits the PrxII gene expression has been shown to partially reverse the radioresistant phenotype in radiation resistant breast cancer cells and sensitizes glioma cells to oxidative stress, highlighting the potential clinical importance of PrxII in radiation resistance in cancer. This article focuses on the role that PrxII may play in chemoresistant breast cancer cells.

AB - Peroxiredoxin (Prx)II belongs to a family of redox-active proteins that use redox-sensitive cysteine in the active site to reduce peroxides. PrxII is induced by various oxidative stimuli and plays an important protective role against oxidative radical damage by reactive oxygen species. PrxII expression levels are correlated with resistance to radiation therapy or certain anti-cancer drugs in radioresistant breast cancer cells, glioblastomas, and head and neck cancer cells as well as in tissue isolated from head and neck patients who do not respond to radiation therapy. Small interfering RNA (siRNA) that inhibits the PrxII gene expression has been shown to partially reverse the radioresistant phenotype in radiation resistant breast cancer cells and sensitizes glioma cells to oxidative stress, highlighting the potential clinical importance of PrxII in radiation resistance in cancer. This article focuses on the role that PrxII may play in chemoresistant breast cancer cells.

KW - Cysteine disulfide bridges

KW - Reactive oxygen species

KW - Redox

KW - siRNA

KW - Targeted therapy

UR - http://www.scopus.com/inward/record.url?scp=84901479010&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901479010&partnerID=8YFLogxK

U2 - 10.2147/BCTT.S61281

DO - 10.2147/BCTT.S61281

M3 - Article

AN - SCOPUS:84901479010

VL - 6

SP - 73

EP - 80

JO - Breast Cancer: Targets and Therapy

JF - Breast Cancer: Targets and Therapy

SN - 1179-1314

ER -